The importance of quality in corrosion-resistant alloys: In biopharmaceutical manufacturing

Pharmaceutical Technology

Volumn 32, Issue 3, 2008, Pages 164-177

  Ahluwalia, Hira ^a   Uhlenkamp, Brian ^b  

^a Material Selection Resources Inc   (United States)

^b DCI Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOY; CHROMIUM; MOLYBDENUM; NICKEL; STAINLESS STEEL;

CLEANING; CORROSION; DRUG INDUSTRY; DRUG MANUFACTURE; EQUIPMENT; GOOD MANUFACTURING PRACTICE; INSTRUMENT STERILIZATION; MATERIALS TESTING; QUALITY CONTROL; REVIEW;

EID: 40949159270     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. Corrosion Costs and Preventive Strategies in the United States, Transportation Equity Act for the 21St Century (TEA-21), US Congress, 1998.
2. Code of Federal Regulations, Title 21, Food and Drugs.
3. American Society of Mechanical Engineers (ASME) Section VIII Div. 1, Boiler and Pressure Vessel Design Code (ASME, New York, 2007).
4. American Society of Mechanical Engineers (ASME) Section IX, Welding (ASME, New York, 2007).
5. American Society of Mechanical Engineers (ASME) Bioprocessing Equipment (ASME, New York, 2005).
6. H. Ahluwalia and B. Uhlenkamp, "The Influence of Microstructures in the Fabrication and Electropolish Finish of Corrosion Resistant Equipment for the BioPharmaceutical Industry," presented at Corrosion 2007, National Association of Corrosion Engineers, Nashville, TN, March 2007.